A study of Parkinson's patients taking dopamine agonists indicates they face a greater risk of uncontrollable sleepiness than patients taking other drugs for the disease, according to a study in the Archives of Neurology. The Harvard study found 22% of the 929 patients taking commonly prescribed drugs such as Boehringer Ingelheim's Mirapex, GlaxoSmithKline's Requip or Eli Lilly's Permax reported at least one episode of falling asleep inappropriately in the previous six months.

Full Story:

Related Summaries